I have been engaged in the study of inflammatory bowel disease (IBD) for nearly four decades and have been treating patients with IBD during this time. My research interests span clinical, basic and translational research and are primarily focused on immunopathologic mechanisms, novel therapeutics and the translation of basic science and genetic findings for use in diagnosis, prognosis and targeted therapeutic selection in IBD."
Learn more about the scientists, faculty members, investigators and other healthcare professionals of the Targan Laboratory, whose dedicated efforts lead to groundbreaking discoveries.
Gonsky R, Fleshner P, Deem RL, Biener-Ramanujan E, Li D, Potdar AA, Bilsborough J, Yang S, McGovern DPB, Targan SR.
Gastroenterology. 2017 Jul;153(1):219-232.
Zhang H, Zheng L, McGovern DP, Hamill AM, Ichikawa R, Kanazawa Y, Luu J, Kumagai K, Cilluffo M, Fukata M, Targan SR, et al.
J Immunol. 2017 Mar 1;198(5):2133-2146.
Thomas LS, Targan SR, Tsuda M, Yu QT, Salumbides BC, Haritunians T, Mengesha E, McGovern DP, Michelsen KS.
J Leukoc Biol. 2017 Mar;101(3):727-737.